American College Of Rheumatology

The American College of Rheumatology is urging CMS to reconsider its current policy of allowing insurers to exclude copay assistance programs from counting toward a patient’s deductible, according to a press release.

Just 62.8% of available pediatric rheumatology program slots were filled for the 2023 appointment year as part of the National Residents Matching Program, according to the American College of Rheumatology.

Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to biologic therapies or conventional synthetic disease-modifying antirheumatic drugs, according to data.

I just got back from Philadelphia and ACR Convergence 2022, and let me start by saying how glad I am that I attended. I met and canvassed the Healio Rheumatology Peer Board members, as well as a large number of friends and professional colleagues, on what they thought about the meeting in an effort to describe what worked for them, as well as what may have missed the mark.

PHILADELPHIA — New classification criteria for pediatric chronic nonbacterial osteomyelitis include chronic bone pain or functional musculoskeletal limitation lasting 6 weeks or longer, according to a speaker at ACR Convergence 2022.

PHILADELPHIA — Looking not only to history, but also to narratives like novels and movies, can help health care professionals understand and move beyond the COVID-19 pandemic, according to the keynote speaker at ACR Convergence 2022.

PHILADELPHIA — The “lanes” of medical organizations such as the American College of Rheumatology are widening, as current events require trusted medical professionals to weigh in, said outgoing ACR president Kenneth G. Saag, MD, MSc.

Patients being treated for rheumatoid arthritis are strongly advised to engage in physical exercise when possible, according to new recommendations from the American College of Rheumatology.

A higher threshold for patient global assessment — 2 cm rather than 1 cm — increases agreement between Boolean and index-based rheumatoid arthritis remission criteria, according to data published in Arthritis & Rheumatology.

Fewer than one in six guidelines put forth by the American College of Rheumatology and EULAR are backed up by head-to-head, randomized clinical trials, according to data published in ACR Open Rheumatology.